[
    [
        {
            "time": "2018-04-04",
            "original_text": "泰格医药：预计一季度净利润同比增长1.85倍-2倍",
            "features": {
                "keywords": [
                    "泰格医药",
                    "净利润",
                    "同比增长",
                    "1.85倍-2倍"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "泰格医药：预计一季度净利润同比增长1.85倍-2倍",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-04",
            "original_text": "绩优+创新！医药行业妖股频出，这两点值得一看",
            "features": {
                "keywords": [
                    "绩优",
                    "创新",
                    "医药行业",
                    "妖股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "绩优+创新！医药行业妖股频出，这两点值得一看",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-04",
            "original_text": "[推荐评级] 医药生物行业2018年二季度策略报告：把握政策利好 聚焦创新和龙头",
            "features": {
                "keywords": [
                    "医药生物",
                    "政策利好",
                    "创新",
                    "龙头"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[推荐评级] 医药生物行业2018年二季度策略报告：把握政策利好 聚焦创新和龙头",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-04-04",
            "original_text": "[增持评级] 医药生物行业点评：国务院政策加码 医药行业供给侧改革提速",
            "features": {
                "keywords": [
                    "医药生物",
                    "国务院",
                    "政策加码",
                    "供给侧改革"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[增持评级] 医药生物行业点评：国务院政策加码 医药行业供给侧改革提速",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-04-04",
            "original_text": "国务院发布仿制药鼓励政策 七股闻风而动",
            "features": {
                "keywords": [
                    "国务院",
                    "仿制药",
                    "鼓励政策",
                    "七股"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国务院发布仿制药鼓励政策 七股闻风而动",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]